MS-Selfie

Home
Notes
MS-Selfie Research
MS-Selfie Microsite
Contact
Q&A
Archive
Leaderboard
About
Molecular mimicry: does it explain how EBV causes MS?
EBV & host genetic predispositions increase your risk of MS by 260x and the presence of antibody responses against three or more cross-reactive peptides…
 • 
Gavin Giovannoni
21
Multidisciplinary team meetings or MDTs
In an era when high-efficacy DMTs are increasingly being prescribed first-line, MDTs should be changed to focus on patients wanting to start low—or…
 • 
Gavin Giovannoni
16
Q&A 57: Is my pseudorelapse due to smouldering MS?
I am hoping that in the future, we will be able to distinguish between true relapses (new focal inflammatory activity) and pseudorelapses by measuring…
 • 
Gavin Giovannoni
23
9:52
Self-agency in MS - is it realistic?
Can healthcare professionals (HCPs) expect their patients with MS to have self-agency and manage their own MS-related symptoms?
 • 
Gavin Giovannoni
47
Q&A 56: Natalizumab switching: adverse events on Tyruko
Patients can experience the nocebo effect when they switch to generic or biosimilar drugs. Are these reports due to the nocebo effect?
 • 
Gavin Giovannoni
8
Can we continue to ignore the evidence that T-cells are fundamental to MS?
Is it not time to take off the B-cell blinkers? Do you think MS-Selfie is the appropriate platform for highlighting key research findings in MS?
 • 
Gavin Giovannoni
54
Q&A 55: Should I have a third course of cladribine?
How effective is a third course of cladribine (Mavenclad) in halting disease progression?
 • 
Gavin Giovannoni
36
7:22
MS-Selfie
MS-Selfie
MS-Selfie helps you self-manage your multiple sclerosis. MS-Selfie consists of the newsletter and the MS-Selfie microsite, which consists of curated content https://msselfie.co.uk/

MS-Selfie

AboutArchiveSitemap
© 2024 Gavin Giovannoni
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture